60 related articles for article (PubMed ID: 25600528)
1. Improving the bioavailability and anticancer effect of the PCA-1/ALKBH3 inhibitor HUHS015 using sodium salt.
Mabuchi M; Shimizu T; Ueda M; Sasakawa Y; Nakao S; Ueda Y; Kawamura A; Tsujikawa K; Tanaka A
In Vivo; 2015; 29(1):39-43. PubMed ID: 25600528
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of prostate cancer antigen-1 (PCA-1/ALKBH3) inhibitors as anti-prostate cancer drugs.
Nakao S; Mabuchi M; Shimizu T; Itoh Y; Takeuchi Y; Ueda M; Mizuno H; Shigi N; Ohshio I; Jinguji K; Ueda Y; Yamamoto M; Furukawa T; Aoki S; Tsujikawa K; Tanaka A
Bioorg Med Chem Lett; 2014 Feb; 24(4):1071-4. PubMed ID: 24461353
[TBL] [Abstract][Full Text] [Related]
3. Novel Metabolically Stable PCA-1/ALKBH3 Inhibitor Has Potent Antiproliferative Effects on DU145 Cells
Ueda M; Shimizu T; Mabuchi M; Horiike K; Kitae K; Hase H; Ueda Y; Tsujikawa K; Tanaka A
Anticancer Res; 2018 Jan; 38(1):211-218. PubMed ID: 29277775
[TBL] [Abstract][Full Text] [Related]
4. anti-tumor effect of AlkB homolog 3 knockdown in hormone- independent prostate cancer cells.
Koike K; Ueda Y; Hase H; Kitae K; Fusamae Y; Masai S; Inagaki T; Saigo Y; Hirasawa S; Nakajima K; Ohshio I; Makino Y; Konishi N; Yamamoto H; Tsujikawa K
Curr Cancer Drug Targets; 2012 Sep; 12(7):847-56. PubMed ID: 22515525
[TBL] [Abstract][Full Text] [Related]
5. PCA-1/ALKBH3 contributes to pancreatic cancer by supporting apoptotic resistance and angiogenesis.
Yamato I; Sho M; Shimada K; Hotta K; Ueda Y; Yasuda S; Shigi N; Konishi N; Tsujikawa K; Nakajima Y
Cancer Res; 2012 Sep; 72(18):4829-39. PubMed ID: 22826605
[TBL] [Abstract][Full Text] [Related]
6. ALKBH3, a human AlkB homologue, contributes to cell survival in human non-small-cell lung cancer.
Tasaki M; Shimada K; Kimura H; Tsujikawa K; Konishi N
Br J Cancer; 2011 Feb; 104(4):700-6. PubMed ID: 21285982
[TBL] [Abstract][Full Text] [Related]
7. DNA unwinding by ASCC3 helicase is coupled to ALKBH3-dependent DNA alkylation repair and cancer cell proliferation.
Dango S; Mosammaparast N; Sowa ME; Xiong LJ; Wu F; Park K; Rubin M; Gygi S; Harper JW; Shi Y
Mol Cell; 2011 Nov; 44(3):373-84. PubMed ID: 22055184
[TBL] [Abstract][Full Text] [Related]
8. ALKBH3 contributes to survival and angiogenesis of human urothelial carcinoma cells through NADPH oxidase and tweak/Fn14/VEGF signals.
Shimada K; Fujii T; Tsujikawa K; Anai S; Fujimoto K; Konishi N
Clin Cancer Res; 2012 Oct; 18(19):5247-55. PubMed ID: 22850567
[TBL] [Abstract][Full Text] [Related]
9. ProstaCaid inhibits tumor growth in a xenograft model of human prostate cancer.
Jiang J; Loganathan J; Eliaz I; Terry C; Sandusky GE; Sliva D
Int J Oncol; 2012 May; 40(5):1339-44. PubMed ID: 22293856
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, pharmacodynamics and metabolism of a novel anticancer agent for prostate cancer.
Yang J; Ahn S; Wu Z; Hwang DJ; Miller DD; Dalton JT
Int J Oncol; 2012 Jul; 41(1):337-44. PubMed ID: 22576690
[TBL] [Abstract][Full Text] [Related]
11. Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model.
Handratta VD; Vasaitis TS; Njar VC; Gediya LK; Kataria R; Chopra P; Newman D; Farquhar R; Guo Z; Qiu Y; Brodie AM
J Med Chem; 2005 Apr; 48(8):2972-84. PubMed ID: 15828836
[TBL] [Abstract][Full Text] [Related]
12. A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I.
Yu CC; Pan SL; Chao SW; Liu SP; Hsu JL; Yang YC; Li TK; Huang WJ; Guh JH
Biochem Pharmacol; 2014 Aug; 90(3):320-30. PubMed ID: 24915421
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence Monitoring of the Oxidative Repair of DNA Alkylation Damage by ALKBH3, a Prostate Cancer Marker.
Beharry AA; Lacoste S; O'Connor TR; Kool ET
J Am Chem Soc; 2016 Mar; 138(11):3647-50. PubMed ID: 26967262
[TBL] [Abstract][Full Text] [Related]
14. Trimethoxy-resveratrol and piceatannol administered orally suppress and inhibit tumor formation and growth in prostate cancer xenografts.
Dias SJ; Li K; Rimando AM; Dhar S; Mizuno CS; Penman AD; Levenson AS
Prostate; 2013 Aug; 73(11):1135-46. PubMed ID: 23657951
[TBL] [Abstract][Full Text] [Related]
15. Indenone derivatives as inhibitor of human DNA dealkylation repair enzyme AlkBH3.
Nigam R; Babu KR; Ghosh T; Kumari B; Akula D; Rath SN; Das P; Anindya R; Khan FA
Bioorg Med Chem; 2018 Aug; 26(14):4100-4112. PubMed ID: 30041948
[TBL] [Abstract][Full Text] [Related]
16. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.
Li X; Wu JB; Chung LW; Huang WC
Oncotarget; 2015 Dec; 6(38):41018-32. PubMed ID: 26512780
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance and therapeutic potential of prostate cancer antigen-1/ALKBH3 in human renal cell carcinoma.
Hotta K; Sho M; Fujimoto K; Shimada K; Yamato I; Anai S; Harada H; Tsujikawa K; Konishi N; Shinohara N; Nakajima Y
Oncol Rep; 2015 Aug; 34(2):648-54. PubMed ID: 26035443
[TBL] [Abstract][Full Text] [Related]
18. Regulation of androgen receptor expression by Z-isochaihulactone mediated by the JNK signaling pathway and might be related to cytotoxicity in prostate cancer.
Liu PY; Lin SZ; Sheu JJ; Lin CT; Lin PC; Chou YW; Huang MH; Chiou TW; Harn HJ
Prostate; 2013 Apr; 73(5):531-41. PubMed ID: 23038474
[TBL] [Abstract][Full Text] [Related]
19. Anticancer activity of stabilized palifosfamide in vivo: schedule effects, oral bioavailability, and enhanced activity with docetaxel and doxorubicin.
Jones B; Komarnitsky P; Miller GT; Amedio J; Wallner BP
Anticancer Drugs; 2012 Feb; 23(2):173-84. PubMed ID: 22027537
[TBL] [Abstract][Full Text] [Related]
20. RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice.
Zhao Z; He J; Kang R; Zhao S; Liu L; Li F
Prostate; 2016 Feb; 76(2):184-98. PubMed ID: 26477693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
